470 related articles for article (PubMed ID: 30462965)
41. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi.
Pönnighaus JM; Fine PE; Sterne JA; Wilson RJ; Msosa E; Gruer PJ; Jenkins PA; Lucas SB; Liomba NG; Bliss L
Lancet; 1992 Mar; 339(8794):636-9. PubMed ID: 1347338
[TBL] [Abstract][Full Text] [Related]
42. [Calmette-Guerin (BCG) vaccination].
Bonnaud F
Rev Prat; 1996 Jun; 46(11):1362-7. PubMed ID: 8794620
[TBL] [Abstract][Full Text] [Related]
43. Health economic evaluation of current vaccination strategies and new vaccines against tuberculosis: a systematic review.
Machlaurin A; Pol SV; Setiawan D; van der Werf TS; Postma MJ
Expert Rev Vaccines; 2019 Sep; 18(9):897-911. PubMed ID: 31369299
[No Abstract] [Full Text] [Related]
44. A novel TB vaccine; towards a strategy based on our understanding of BCG failure.
Agger EM; Andersen P
Vaccine; 2002 Nov; 21(1-2):7-14. PubMed ID: 12443657
[TBL] [Abstract][Full Text] [Related]
45. Current status of new tuberculosis vaccine in children.
Pang Y; Zhao A; Cohen C; Kang W; Lu J; Wang G; Zhao Y; Zheng S
Hum Vaccin Immunother; 2016 Apr; 12(4):960-70. PubMed ID: 27002369
[TBL] [Abstract][Full Text] [Related]
46. To BCG or not to BCG? Preventing travel-associated tuberculosis in children.
Ritz N; Connell TG; Curtis N
Vaccine; 2008 Nov; 26(47):5905-10. PubMed ID: 18804139
[TBL] [Abstract][Full Text] [Related]
47. The effect of bacille Calmette-Guérin vaccination at birth on immune response in China.
Pang Y; Kang W; Zhao A; Liu G; Du W; Xu M; Wang G; Zhao Y; Zheng S
Vaccine; 2015 Jan; 33(1):209-13. PubMed ID: 25454854
[TBL] [Abstract][Full Text] [Related]
48. Novel vaccination strategies against tuberculosis.
Andersen P; Kaufmann SH
Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890836
[TBL] [Abstract][Full Text] [Related]
49. Manipulation of BCG vaccine: a double-edged sword.
Singh VK; Srivastava R; Srivastava BS
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):535-43. PubMed ID: 26810060
[TBL] [Abstract][Full Text] [Related]
50. Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques.
Dijkman K; Sombroek CC; Vervenne RAW; Hofman SO; Boot C; Remarque EJ; Kocken CHM; Ottenhoff THM; Kondova I; Khayum MA; Haanstra KG; Vierboom MPM; Verreck FAW
Nat Med; 2019 Feb; 25(2):255-262. PubMed ID: 30664782
[TBL] [Abstract][Full Text] [Related]
51. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
[TBL] [Abstract][Full Text] [Related]
52. Paediatric tuberculosis during universal and selective
Kontturi A; Kekomäki S; Soini H; Ollgren J; Salo E
Euro Surveill; 2021 Mar; 26(11):. PubMed ID: 33739257
[TBL] [Abstract][Full Text] [Related]
53. A review of the literature on the economics of vaccination against TB.
Tu HA; Vu HD; Rozenbaum MH; Woerdenbag HJ; Postma MJ
Expert Rev Vaccines; 2012 Mar; 11(3):303-17. PubMed ID: 22380823
[TBL] [Abstract][Full Text] [Related]
54. Bacillus Calmette-Guérin (BCG) vaccination patterns in the province of Québec, Canada, 1956-1974.
Rousseau MC; Conus F; Kâ K; El-Zein M; Parent MÉ; Menzies D
Vaccine; 2017 Aug; 35(36):4777-4784. PubMed ID: 28705514
[TBL] [Abstract][Full Text] [Related]
55. Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection.
Zhang M; Dong C; Xiong S
Hum Vaccin Immunother; 2017 Apr; 13(4):816-822. PubMed ID: 27960596
[TBL] [Abstract][Full Text] [Related]
56. Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations.
Pooransingh S; Sakhamuri S
Emerg Infect Dis; 2020 Mar; 26(3):624-625. PubMed ID: 31922950
[TBL] [Abstract][Full Text] [Related]
57. Post-exposure vaccination with the vaccine candidate Bacillus Calmette-Guérin ΔureC::hly induces superior protection in a mouse model of subclinical tuberculosis.
Gengenbacher M; Kaiser P; Schuerer S; Lazar D; Kaufmann SH
Microbes Infect; 2016 May; 18(5):364-8. PubMed ID: 26994939
[TBL] [Abstract][Full Text] [Related]
58. BCG scarring and improved child survival: a combined analysis of studies of BCG scarring.
Benn CS; Roth A; Garly ML; Fisker AB; Schaltz-Buchholzer F; Timmermann A; Berendsen M; Aaby P
J Intern Med; 2020 Dec; 288(6):614-624. PubMed ID: 32301189
[TBL] [Abstract][Full Text] [Related]
59. The effectiveness of bacillus Calmette-Guérin (BCG) vaccination against tuberculosis. A case-control study in Treaty Indians, Alberta, Canada.
Houston S; Fanning A; Soskolne CL; Fraser N
Am J Epidemiol; 1990 Feb; 131(2):340-8. PubMed ID: 2296986
[TBL] [Abstract][Full Text] [Related]
60. Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration.
Ayoub BM; Ramadan E; Ashoush N; Tadros MM; Hendy MS; Elmazar MM; Mousa SA
Pharmazie; 2020 Aug; 75(8):375-380. PubMed ID: 32758336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
